Bronchiolitis Obliterans
Symptoms, Doctors, Treatments, Advances & More

Bronchiolitis Obliterans Overview

Save information for later
Sign Up

Learn About Bronchiolitis Obliterans

What is the definition of Bronchiolitis Obliterans?
Bronchiolitis obliterans is an inflammatory condition that affects the lung's tiniest airways, the bronchioles. In affected people, the bronchioles may become damaged and inflamed leading to extensive scarring that blocks the airways. Symptoms of the condition include a dry cough; shortness of breath; and/or fatigue and wheezing in the absence of a cold or asthma. Many different chemicals (such as nitrogen oxides, ammonia, welding fumes or food flavoring fumes) and respiratory infections can cause lung injury that leads to Bronchiolitis obliterans. It can also be associated with rheumatoid arthritis and graft-versus-host disease following a lung or hematopoietic cell transplantation. Another similarly named disease, Bronchiolitis obliterans organizing pneumonia, is a different disease.
What are the alternative names for Bronchiolitis Obliterans?
  • Bronchiolitis obliterans
  • Obliterative bronchiolitis
Who are the top Bronchiolitis Obliterans Local Doctors?
Elite in Bronchiolitis Obliterans
Dr. Vibha N. Lama
Intensive Care Medicine
Elite in Bronchiolitis Obliterans
Dr. Vibha N. Lama
Intensive Care Medicine
Referral may be required

Emory University Hospital

1364 Clifton Road Northeast, 
Atlanta, GA 
404-712-2000
Experience:
34+ years
Languages Spoken:
English
See accepted insurances

Vibha Lama is an Intensive Care Medicine provider practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 34 years. Dr. Lama is rated as an Elite provider by MediFind in the treatment of Bronchiolitis Obliterans. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Bronchiolitis Obliterans, Bronchitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Lama is board certified in American Board Of Internal Medicine, 2001.

Elite in Bronchiolitis Obliterans
Dr. John J. Osterholzer
Pulmonary Medicine | Intensive Care Medicine | Internal Medicine
Elite in Bronchiolitis Obliterans
Dr. John J. Osterholzer
Pulmonary Medicine | Intensive Care Medicine | Internal Medicine
Referral may be required

U Of M Pulmonary

1500 E Medical Center Dr, Spc 5360, 
Ann Arbor, MI 
734-615-3217
Languages Spoken:
English
See accepted insurances

John Osterholzer is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Osterholzer is rated as an Elite provider by MediFind in the treatment of Bronchiolitis Obliterans. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Bronchiolitis Obliterans, Bronchitis, Pulmonary Fibrosis, and Pneumonia. Dr. Osterholzer is board certified in Pulmonary Disease and Critical Care Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Bronchiolitis Obliterans
Dr. Maria C. Garcia
Pulmonary Medicine
Distinguished in Bronchiolitis Obliterans
Dr. Maria C. Garcia
Pulmonary Medicine
Referral may be required

SOFHA Pulmonology

310 N State Of Franklin Rd, Ste 303, 
Johnson City, TN 
423-926-8181
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maria Garcia is a Pulmonary Medicine provider practicing medicine in Johnson City, Tennessee. Dr. Garcia is rated as a Distinguished provider by MediFind in the treatment of Bronchiolitis Obliterans. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma in Children, Lung Nodules, and Advanced Bronchoscopy. Dr. Garcia is board certified in American Board Of Internal Medicine.

View All Doctors
What are the latest Bronchiolitis Obliterans Clinical Trials?
An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation
An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation
Enrollment Status: Recruiting
Publish Date: June 10, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: The goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT) recipients who have been newly diagnosed or have developing (early stage) bronchiolitis obliterans syndrome (BOS). The name of the study drugs involved in this study are: * Belumosudil (an immunotherapy) * Fluticasone (an intranasal cortic...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Predicting the Quality of Response to Specific Treatments (PQRST)
Predicting the Quality of Response to Specific Treatments (PQRST)
Enrollment Status: Recruiting
Publish Date: May 20, 2026
Intervention Type: Other, Procedure

Summary: This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and after treatment initiation may help doctors identify changes that may predict treatment response.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center